Oura has introduced new features in its app, specifically designed to support expecting mothers and women experiencing perimenopause, under the titles Pregnancy Insights and Perimenopause Check-In.

These tools allow users to complete a survey for personalized assessments, generating a PDF report that summarizes symptoms and biometric trends for easy sharing with healthcare providers.

The dual launch is part of Oura's broader strategy to enhance health tracking capabilities, moving towards metabolic health and continuous glucose monitoring.

The Oura Ring 4, which is priced at $400, requires a monthly subscription fee of $6 for app access and data features.

These enhancements are significant as they address the often-overlooked health transitions women face during pregnancy and menopause, providing essential knowledge and resources for better health management.

Oura aims to fill a gap in tech solutions for women's health, particularly during these critical life stages that are frequently misunderstood and underserved.

As more data is collected, the app's features are expected to adapt and become increasingly personalized over time.

Oura emphasizes user privacy and data security, allowing users to control their data rights and ensuring they can opt-in or out of features.

Users are encouraged to take the monthly MRS for optimal symptom tracking, although this is flexible based on individual needs.

The app also allows users to report unusual health data changes, providing guidance on necessary steps to take.

While competitors like Apple and Samsung offer menstrual and fertility tracking, Oura's tools specifically target the perimenopause stage, distinguishing it in the wearables market.

The rollout date for the new Pregnancy Insights feature has not yet been confirmed, but it is anticipated to launch in the coming weeks.